Andulfa 100mg Injection

Andulfa 100mg injection is an antifungal medication belonging to the class of fungal ergosterol synthesis inhibitors. It contains the active ingredient Anidulafungin and is used to treat certain invasive fungal infections. The medication is effective against various types of invasive candidiasis, including candidemia (Candida bloodstream infection) and oesophageal candidiasis (fungal infection of the oesophagus). Invasive candidiasis occurs when Candida yeasts enter the bloodstream or other internal organs, causing systemic infections.

This drug is contraindicated in individuals with known hypersensitivity or allergy to Anidulafungin or any component of the formulation. If patients develop liver problems during treatment with this medication, their doctor may decide to monitor liver function more closely. Andulfa 100mg injection is primarily metabolised in the liver, making it important to assess liver function regularly, particularly in patients with pre-existing liver conditions.

Inform your physician, including anaesthesiologists, about your treatment with this drug, especially before undergoing surgery or receiving anaesthesia. The combination of certain anaesthetics with this medication could interact, so medical professionals must be aware of your medication history. Pay attention to any unusual symptoms such as shortness of breath, breathing difficulties, lightheadedness, or dizziness during treatment with this drug. If you experience any of these symptoms, contact your physician immediately.

The safety of Andulfa 100mg injection in pregnant women is unknown. It is not recommended during pregnancy due to limited data. If a woman of childbearing age is prescribed this drug, it is essential to use effective contraception during the treatment period to avoid pregnancy. The effect of this drug on breastfeeding women is not known. Breastfeeding women should contact their doctor for further advice before taking this medicine.

Treatment of serious fungal infections

Andulfa 100mg injection works by inhibiting the beta-glucan synthesis in the cell walls of susceptible fungi. This disruption weakens the fungal cell wall, leading to the death of the fungus.

Andulfa 100mg injection is administered directly into the vein intravenously (IV). It is available as a powder for reconstitution, and a physician will prepare and administer the medication through a vein. The IV infusion is usually given over a period of one to two hours.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Convulsion (seizure) Flushing Rash, pruritus (itching) Hot flush Hives Wheezing Coughing Difficulty of breathing Common Low blood potassium (hypokalaemia) Diarrhea Nausea Headache Vomiting

Andulfa 100mg injection is given through intravenous infusion. Some individuals may experience infusion-related reactions, including a rash, hives, itching, or redness at the infusion site. If you notice any of these symptoms during or after the infusion, notify your physician immediately.